What is Sarcopenia?
Sarcopenia is the progressive, age-related loss of skeletal muscle mass, strength, and function.
Derived from the Greek words “sarx” (flesh) and “penia” (poverty), the term describes a condition that affects virtually all adults as they age.
Sarcopenia is now recognised as a disease by the World Health Organization (ICD-10 code M62.84).
The consequences of sarcopenia extend beyond reduced strength: it increases fall risk, impairs mobility, reduces metabolic rate, worsens insulin sensitivity, and is independently associated with higher mortality.
In Malaysia’s ageing population, sarcopenia is an increasingly relevant public health concern.
Relevance to Creatine Supplementation
Creatine is one of the most promising nutritional interventions for sarcopenia when combined with resistance exercise.
Multiple meta-analyses have demonstrated that creatine supplementation enhances the effects of resistance training in older adults, producing greater gains in lean body mass, upper and lower body strength, and functional capacity compared to resistance training alone.
The mechanisms are multi-faceted: creatine increases phosphocreatine stores for better training performance, promotes cell volumization that stimulates protein synthesis, and may reduce markers of muscle protein breakdown.
For ageing adults in Malaysia, where resistance training adoption is growing, creatine supplementation at 3-5 g/day alongside exercise represents an affordable, evidence-based strategy to combat muscle loss.
Related Terms
- Ergogenic Aid — Creatine as a performance enhancer for older adults
- Cell Volumization — The muscle-swelling effect that supports protein synthesis
- Neuroprotection — Another age-relevant benefit of creatine
- Maintenance Dose — The recommended daily intake for combating sarcopenia
Sources & References
Full citations available in our Research Library.